Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001672659-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 14, 2026 |
| Document Date | Jan 9, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
25,554
Total Value
$318,914.98
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 9, 2026 | Exercise/Conversion | 2,170 | $16.00 | $34,720.00 | 63,974 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 9, 2026 | Sale | 2,170 | $33.27 | $72,195.90 | 61,804 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 12, 2026 | Exercise/Conversion | 6,348 | $1.08 | $6,855.84 | 68,152 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 12, 2026 | Sale | 6,348 | $32.32 | $205,143.24 | 61,804 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 9, 2026 | Exercise/Conversion | 2,170 | $0.00 | $0.00 | 28,218 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jan 12, 2026 | Exercise/Conversion | 6,348 | $0.00 | $0.00 | 38,092 | Direct | โ | View Details |